The Latest Cardiac and Vascular News
ALISO VIEJO, Calif., June 24, 2020 /PRNewswire/ — Okami Medical Inc., announced today the close of a Series D financing totaling $7.2 million. The financing was led by U.S. Venture Partners and was joined by members of Okami’s board of directors and medical device industry veterans. The financing provides Okami, the second portfolio company of […]
SALT LAKE CITY, June 24, 2020 /PRNewswire/ — Biomerics, LLC, a mid-market medical device contract manufacturer specializing in interventional and radiology markets, launched an online store to sell medical balloons. This new e-Commerce platform will sell a range of off-the-shelf Nylon, PET, and LDPE medical balloons. The fast-turn store enables engineers to […]
Scientific advisory board composed of thought leaders in electrophysiology and treatment of atrial fibrillation MENLO PARK, Calif., June 23, 2020 /PRNewswire/ — Ablacon, Inc., an Ajax Health-backed company, announced today the formation of its Scientific Advisory Board (SAB). The SAB will be composed of four internationally recognized thought leaders in the field of electrophysiology […]
Richard Cappetta has been appointed Chairman of the Board and Yossi Mazel will be the new CEO TEL AVIV, Israel, June 23, 2020 /PRNewswire/ — Bendit Technologies, an industry leader in the development of steerable microcatheters, announced today that Richard Cappetta has been appointed as its Chairman of the Board. Together with this appointment, it was announced that Yossi […]
SALT LAKE CITY–(BUSINESS WIRE)–Heart valve innovator Foldax®, a company reinventing every aspect of the heart valve, from material to design to manufacturing, today announced the closing of a $20 million Series D round of funding. MemorialCare Innovation Fund (MCIF) led the round, with Angel Physicians Fund (APF) and Sayan Bioventures joining […]
BURLINGTON, Mass., June 22, 2020 (GLOBE NEWSWIRE) — LeMaitre Vascular, Inc. (Nasdaq: LMAT) announced that it has acquired the business and assets of Artegraft, Inc. for $90.0 million, including $72.5 million in cash paid at closing ($65.0 million to Artegraft plus $7.5 in escrow to be released December 31, 2021) as […]
Paragonix expands Boards to support rapid commercial growth in the heart transplant market CAMBRIDGE, Mass.–(BUSINESS WIRE)–Paragonix Technologies, Inc. a commercial stage company and leader in organ preservation and transport technology, today announced that Alexander K. Arrow, MD, CFA has joined its Board of Directors. Dr. Arrow is a medical technology […]
IRVINE, Calif.–(BUSINESS WIRE)–Endologix, Inc. (Nasdaq: ELGX) (“Endologix” or the “Company”), a developer and marketer of innovative treatments for aortic disorders, today announced that Vaseem Mahboob, Chief Financial Officer (CFO), will be departing the Company effective July 1, 2020 to become CFO of a private global healthcare company. Cindy Pinto, Vice […]
ATLANTA, June 19, 2020 /PRNewswire/ — CryoLife, Inc. (NYSE: CRY) (“CryoLife” or “the Company”), a leading cardiac and vascular surgery company focused on aortic disease, today announced the pricing of $100 million aggregate principal amount of 4.250% convertible senior notes due 2025 (the “Notes”) in a private placement to qualified institutional buyers pursuant to Rule 144A under […]
ST. PAUL, Minn.–(BUSINESS WIRE)–Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced that the underwriters of its recent public offering of common stock have fully exercised their option resulting in the issuance […]
